Science and Research

An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma

BACKGROUND: Asthma is stratified into type 2-high and type 2-low inflammatory phenotypes. Limited success has been achieved in developing drugs that target type 2-low inflammation. Previous studies have linked IL-6 signaling to severe asthma. IL-6 cooperates with soluble-IL-6R

  • El-Husseini, Z. W.
  • Khalenkow, D.
  • Lan, A.
  • van der Molen, T.
  • Brightling, C.
  • Papi, A.
  • Rabe, K. F.
  • Siddiqui, S.
  • Singh, D.
  • Kraft, M.
  • Beghe, B.
  • van den Berge, M.
  • van Gosliga, D.
  • Nawijn, M. C.
  • Rose-John, S.
  • Koppelman, G. H.
  • Gosens, R.

Keywords

  • Humans
  • *Asthma/diagnosis/drug therapy/genetics
  • Cytokine Receptor gp130/genetics/metabolism
  • Inflammation
  • *Interleukin-6/metabolism
  • Receptors, Interleukin-6/genetics/metabolism
  • Signal Transduction
Publication details
DOI: 10.1186/s12931-023-02617-w
Journal: Respir Res
Pages: 308 
Number: 1
Work Type: Original
Location: ARCN
Disease Area: AA
Partner / Member: CAU, Ghd
Access-Number: 38062491

DZL Engagements

chevron-down